WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass351.60%1,086,238$1.54MInsider
Steen Knudsen40.45%124,976$177.47kInsider
Two Sigma Securities LLC12.15%37,550$53.32kInstitution
Duncan Moore7.34%22,672$32.19kInsider
Thomas Jensen5.77%17,841$25.33kInsider
Virtu Financial LLC4.86%15,005$21.31kInstitution
Tower Research Capital LLC Trc1.79%5,537$7.86kInstitution
Marie Foegh1.29%3,988$5.66kInsider
Soren Gade Jensen0.91%2,800$3.98kInsider
Wells Fargo Company0.01%32$45.44Institution

1 of 2

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR4.41%95.59%
APVO34.00%66.00%
BPTS0.00%0.00%
VRAX7.37%0.00%
SPRC0.68%0.00%

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 18.81% institutional shareholders, 407.36% Allarity Therapeutics insiders, and 0.00% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 351.60% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.49M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.